Grace Muzanyi

999 total citations
14 papers, 337 citations indexed

About

Grace Muzanyi is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Grace Muzanyi has authored 14 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Grace Muzanyi's work include Tuberculosis Research and Epidemiology (10 papers), Diagnosis and treatment of tuberculosis (3 papers) and Mycobacterium research and diagnosis (3 papers). Grace Muzanyi is often cited by papers focused on Tuberculosis Research and Epidemiology (10 papers), Diagnosis and treatment of tuberculosis (3 papers) and Mycobacterium research and diagnosis (3 papers). Grace Muzanyi collaborates with scholars based in Uganda, United States and Spain. Grace Muzanyi's co-authors include John L. Johnson, Marc Weiner, Payam Nahid, Nebojša Janjić, Urs A. Ochsner, Leah G. Jarlsberg, David G. Sterling, Mary Ann De Groote, Stefan Goldberg and Andrew Vernon and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and The Journal of Infectious Diseases.

In The Last Decade

Grace Muzanyi

11 papers receiving 323 citations

Peers

Grace Muzanyi
Liang Fu China
Elizabeth Harausz United States
Edward Lyon United States
Neesha Rockwood United Kingdom
Jeannine du Bois United States
Natasha Strydom United States
Liang Fu China
Grace Muzanyi
Citations per year, relative to Grace Muzanyi Grace Muzanyi (= 1×) peers Liang Fu

Countries citing papers authored by Grace Muzanyi

Since Specialization
Citations

This map shows the geographic impact of Grace Muzanyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace Muzanyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace Muzanyi more than expected).

Fields of papers citing papers by Grace Muzanyi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace Muzanyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace Muzanyi. The network helps show where Grace Muzanyi may publish in the future.

Co-authorship network of co-authors of Grace Muzanyi

This figure shows the co-authorship network connecting the top 25 collaborators of Grace Muzanyi. A scholar is included among the top collaborators of Grace Muzanyi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grace Muzanyi. Grace Muzanyi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Muzanyi, Grace, et al.. (2025). Severe Tuberculosis. Medical Clinics of North America. 109(3). 641–650.
3.
Mangan, Joan M., Mike Frick, Lindsay McKenna, et al.. (2024). Facilitators and barriers to adolescent participation in a TB clinical trial. The International Journal of Tuberculosis and Lung Disease. 28(5). 243–248.
4.
Muzanyi, Grace, et al.. (2021). The threat of persistent bacteria and fungi contamination in tuberculosis sputum cultures. African Health Sciences. 21(2). 628–632. 1 indexed citations
5.
Muzanyi, Grace, et al.. (2020). Level of education and preferred language of informed consent for clinical research in a multi-lingual community. African Health Sciences. 20(2). 955–959. 5 indexed citations
6.
Muzanyi, Grace, et al.. (2019). Predictors of recurrent TB in sputum smear and culture positive adults: a prospective cohort study. African Health Sciences. 19(2). 2091–2091. 2 indexed citations
7.
Bark, Chung Wung, Bonnie Thiel, Sam Ogwang, et al.. (2018). Sputum smear-positive, culture-negative state during anti-tuberculosis treatment in the MGIT liquid culture era. The International Journal of Tuberculosis and Lung Disease. 22(3). 306–308. 2 indexed citations
8.
Dorman, Susan E., Radojka M. Savić, Stefan Goldberg, et al.. (2014). Daily Rifapentine for Treatment of Pulmonary Tuberculosis. A Randomized, Dose-Ranging Trial. American Journal of Respiratory and Critical Care Medicine. 191(3). 333–343. 76 indexed citations
9.
Nahid, Payam, Erin Bliven-Sizemore, Leah G. Jarlsberg, et al.. (2014). Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis. Tuberculosis. 94(3). 187–196. 50 indexed citations
10.
Hales, Craig M., Charles M. Heilig, Richard E. Chaisson, et al.. (2013). The Association between Symptoms and Microbiologically Defined Response to Tuberculosis Treatment. Annals of the American Thoracic Society. 10(1). 18–25. 18 indexed citations
11.
Groote, Mary Ann De, Payam Nahid, Leah G. Jarlsberg, et al.. (2013). Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment. PLoS ONE. 8(4). e61002–e61002. 89 indexed citations
12.
Dorman, Susan E., Stefan Goldberg, Jason E. Stout, et al.. (2012). Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium. The Journal of Infectious Diseases. 206(7). 1030–1040. 85 indexed citations
13.
Nsubuga, Peter, Grace Muzanyi, Micheal Mugerwa, et al.. (2012). Reasons for non-participation in an international multicenter trial of a new drug for tuberculosis treatment. The International Journal of Tuberculosis and Lung Disease. 16(4). 480–485. 6 indexed citations
14.
Muzanyi, Grace, et al.. (2011). Impact of directly observed sputum collection on sputum culture contamination rates.. PubMed. 11(4). 605–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026